NASDAQ · DCBO
Docebo financials
$22.57−1.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q1 '23 Mar 31 | Q4 '22 Dec 31 | Q3 '22 Sep 30 | Q2 '22 Jun 30 | Q1 '22 Mar 31 | Q4 '21 Dec 31 | Q3 '21 Sep 30 | Q2 '21 Jun 30 | Q1 '21 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $41.5M | $39.0M | $37.0M | $34.9M | $32.1M | $29.8M | $27.1M | $25.6M | $21.7M |
| Gross profit | — | — | — | $33.4M | $31.4M | $29.8M | $28.0M | $25.5M | $23.7M | $21.4M | $20.5M | $17.9M |
| Gross margin | — | — | — | 80.6% | 80.7% | 80.7% | 80.0% | 79.6% | 79.6% | 79.0% | 79.9% | 82.2% |
| Operating income | — | — | — | -$274.0K | $489.0K | -$1.2M | -$2.7M | -$3.5M | -$2.8M | -$3.3M | -$3.2M | -$3.7M |
| Net income | — | — | — | $1.2M | $1.6M | $10.3M | $2.1M | -$7.0M | -$1.4M | $661.0K | -$7.2M | -$5.6M |
| Net margin | — | — | — | 3.0% | 4.1% | 27.8% | 6.0% | −21.7% | −4.8% | 2.4% | −28.1% | −26.0% |
| Diluted EPS | — | — | — | $0.04 | $0.05 | $0.30 | $0.06 | $-0.21 | $-0.04 | $0.02 | $-0.22 | $-0.17 |
| EBITDA | $0.00 | $0.00 | $0.00 | $433.0K | $489.0K | -$626.0K | -$2.2M | -$2.9M | -$2.3M | -$2.8M | -$2.7M | -$3.2M |
| Operating cash flow | — | — | — | -$2.2M | $2.2M | $975.0K | $1.1M | -$2.0M | -$30.0K | -$410.0K | -$631.0K | -$2.2M |
| Free cash flow | — | — | — | -$2.3M | $2.0M | $624.0K | $886.0K | -$2.3M | -$176.0K | -$1.0M | -$831.0K | -$2.4M |
| Diluted shares | 29.4M | 31.0M | 33.7M | 34.2M | 35.1M | 34.1M | 34.0M | 33.0M | 31.8M | 34.1M | 32.8M | 32.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.0M | $92.5M | $72.0M | $215.8M | $216.3M | $212.7M |
| Short-term investments | $0.00 | $0.00 | $83.0K | — | $0.00 | — |
| Total debt | $0.00 | $0.00 | $0.00 | $3.1M | $0.00 | $3.1M |
| Total assets | $206.6M | $190.7M | $158.4M | $295.2M | $283.7M | $270.7M |
| Total liabilities | $132.6M | $133.0M | $107.7M | $99.9M | $91.5M | $82.2M |
| Shareholders' equity | $74.1M | $57.8M | $50.7M | $195.2M | $192.2M | $188.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology